{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:32:36Z","timestamp":1774121556872,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002876","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,4,20]],"date-time":"2005-04-20T00:00:00Z","timestamp":1113955200000}}],"reference-count":91,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002876.pub2","type":"journal-article","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T14:35:41Z","timestamp":1114180541000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Tiotropium for stable chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2013","author":[{"given":"R Graham","family":"Barr","sequence":"first","affiliation":[{"name":"Columbia-Presbyterian Medical Center; Division of General Medicine, PH-9 East Room 105; 622 West 168th Street New York NY USA 10032"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bourbeau","sequence":"additional","affiliation":[{"name":"McGill University Health Centre; Respiratory Division, Department of Medicine; Montreal Chest Institute 3650 St-Urbain Montreal QC Canada H2X 2P4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"Camargo Jr","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Department of Emergency Medicine; 326 Cambridge St, Suite 410 Boston Massachusetts USA 02114"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"key":"10.1002\/14651858.CD002876.pub2-BIB0001|cit1","first-page":"S43","article-title":"Efficacy of tiotropium (Spiriva) in COPD of different severities (abstract)","volume":"58","author":"Beeh","year":"2004","journal-title":"Pneumologie"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0002|cit2","first-page":"A519","article-title":"Efficacy of tiotropium in patients with mild-to-moderate COPD (abstract)","volume":"169","author":"Beeh","year":"2004","journal-title":"Amercian Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/thorax.58.5.399","article-title":"Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD","volume":"58","author":"Brusasco","year":"2003","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/thorax.58.10.855","article-title":"Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD002876.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1378\/chest.118.5.1294","article-title":"The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group","volume":"118","author":"Casaburi","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1378\/chest.124.5.1743","article-title":"Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes","volume":"124","author":"Celli","year":"2003","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1378\/chest.122.1.47","article-title":"A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol","volume":"122","author":"Donohue","year":"2002","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1164\/ajrccm.161.4.9903044","article-title":"Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease","volume":"161","author":"Littner","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0010|cit10","unstructured":"Niewoehner D Rice K Cote C Paulson D Cooper JA Korducki L Cassino C Kestern S Reduced COPD exacerbations and associated health care utilization with once-daily tiotropium in the VA Medical System [abstract] American Journal of Respiratory Critical Care and Medicine 2004 A207"},{"issue":"5","key":"10.1002\/14651858.CD002876.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","article-title":"Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial","volume":"143","author":"Niewoehner","year":"2005","journal-title":"Annals of internal medicine"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD","volume":"23","author":"O'Donnell","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD002876.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group","volume":"55","author":"Noord","year":"2000","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1183\/09031936.02.00238702","article-title":"Dutch\/Belgium Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium","volume":"19","author":"Vincken","year":"2002","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD002876.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pupt.2003.09.001","article-title":"The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD","volume":"17","author":"Cazzola","year":"2004","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0954-6111(03)00131-8","article-title":"Tolerance to bronchodilating effects of salmeterol in COPD","volume":"97","author":"Donohue","year":"2003","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1183\/09031936.93.06071031","article-title":"Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD","volume":"6","author":"Maesen","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/09031936.95.08091506","article-title":"Tiotropium bromide, a new long-acting anti-muscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease(COPD). Dutch Study Group","volume":"8","author":"Maesen","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/ajrccm.154.4.8887578","article-title":"Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma","volume":"154","author":"O'Connor","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.123.5.1441","article-title":"Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses","volume":"123","author":"Tashkin","year":"2003","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1183\/09031936.02.00238002","article-title":"Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease","volume":"19","author":"Noord","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","article-title":"Minimal important difference of the transitional dyspnoea index in a multinational clinical trial","volume":"21","author":"Witek","year":"2003","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0023|cit23","article-title":"Effect of a 12-week treatment with inhaled tiotropium (18 mcg once daily) on lung function and static lung volumes in stable, moderate to severe COPD patients. Correlation to dyspnoea scales","author":"Boehringer","journal-title":"http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0024|cit24","unstructured":"Boehringer Ingelheim A comparison of the effects of Tiotropium (18 mcg) Inhalation Capsule q.d. and Salmeterol (50 mcg) Inhalation Aerosol b.i.d. on arterial blood gases in a double-blind, double-dummy, 4-week crossover study in patients with chronic obstructive pulmonary disease (COPD) http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0025|cit25","article-title":"A comparison of 18 mcg of Tiotropium inhalation capsules and atrovent metered dose inhaler (2 puffs of 20 mcg, 4 times daily) in a double-blind, double-dummy, efficacy and safety study in adults with chronic obstructive pulmonary disease (COPD)","author":"205.244","journal-title":"http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0026|cit26","article-title":"A randomized, double blind, placebo controlled trial to compare the effect of tiotropium inhalation capsules on exercise tolerance in patients with COPD participating in 8 weeks of pulmonary rehabilitation","author":"205.247","journal-title":"http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0027|cit27","unstructured":"Boehringer Ingelheim A randomised, double-blind placebo controlled, parallel group efficacy and safety comparison of one-year treatment of two doses (5 mcg [2 actuations of 2.5 mcg] and 10 mcg [2 actuations of 5 mcg]) of tiotropium inhalation solution delivered by the Respimat\u00ae inhaler in patients with chronic obstructive pulmonary disease (COPD) http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0028|cit28","unstructured":"Boehringer Ingelheim A randomised, double-blind, placebo-controlled, parallel group efficacy and safety comparison of one-year treatment of two doses (5 mcg [2 actuations of 2.5 mcg] and 10 mcg [2 actuations of 5 mcg]) of Tiotropium Inhalation Solution Delivered by the Respimat\u00ae Inhaler in Patients with Chronic Obstructive Pulmonary Disease (COPD) http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0029|cit29","article-title":"Acute and long-term effects of once daily oral inhalation of tiotropium 18 mcg dry powder inhalation capsules in a placebo controlled parallel group design study in patients with Chronic Obstructive Pulmonary Disease (COPD) of different severity","author":"Boehringer","journal-title":"http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0030|cit30","unstructured":"Boehringer Ingelheim A randomised, double-blind, parallel-group, placebo-controlled study to evaluate the changes in inflammatory markers and in induced sputum following treatment with Tiotropium inhalation capsules 18 mcg once daily in patients with chronic obstructive pulmonary disease (COPD) http:\/\/trials.boehringer-ingelheim.com\/Trial_Results (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0031|cit31","unstructured":"Briggs D Covelli H Lapidus R Bhattacharya S Kesten S Cassino C Improved daytime spirometric efficacy of tiotropium compared to salmeterol in COPD patients American Thoracic Society 100th International Conference, May 21-26 2004 C22 Poster 511"},{"issue":"6","key":"10.1002\/14651858.CD002876.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pupt.2005.02.013","article-title":"Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD","volume":"18","author":"Briggs Jr","year":"2005","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0033|cit33","first-page":"D14","article-title":"Improvement in exercise endurance with the combination of tiotropium and rehabilitative exercise training in COPD patients","author":"Casaburi","year":"2004","journal-title":"American Thoracic Society 100th International Conference, May 21-26"},{"issue":"3","key":"10.1002\/14651858.CD002876.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1378\/chest.127.3.809","article-title":"Improvement in exercise tolerance with the combination of Tiotropium and pulmonary rehabilitation in patients with COPD","volume":"127","author":"Casaburi","year":"2005","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0035|cit35","unstructured":"Cooper CB Kukafka D Casburi R Kesten S Tiotropium augments improvements in dyspnea and health-related quality of life following pulmonary rehabilitation in COPD patients American Thoracic Society 100th International Conference, May 21-26, 2004, Orlando 2004 C22 Poster 507"},{"issue":"12","key":"10.1002\/14651858.CD002876.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1592\/phco.2005.25.12.1708","article-title":"Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease","volume":"25","author":"Covelli","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD002876.pub2-BIB0037|cit37","first-page":"837s","article-title":"Absence of electrocardiographic findings with daily Tiotropium in patients with chronic obstructive pulmonary disease","volume":"126","author":"Kesten","year":"2004","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0038|cit38","unstructured":"Criner GJ Johnson P Cassino C Conoscenti C Efficacy of tiotropium inhalation powder in COPD patients of African descent Proceedings of the American Thoracic Society 2006 A112; Poster J19"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0039|cit39","first-page":"C47 Poster F78","article-title":"Evaluation of the response of Filipino COPD patients to Tiotropium (EVEREST STUDY)","author":"Guia","year":"2004","journal-title":"American Thoracic Society 100th International Conference, May 21-26"},{"issue":"9","key":"10.1002\/14651858.CD002876.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0929-6646(09)60198-4","article-title":"Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan","volume":"105","author":"Hsu","year":"2006","journal-title":"Journal of the Formosan Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD002876.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.rmed.2006.07.008","article-title":"Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: A randomized study","volume":"101","author":"Incorvaia","year":"2007","journal-title":"Respiratory Medicine"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0042|cit42","first-page":"289s","article-title":"Spirometric outcomes of COPD patients with tiotropium compared with salmeterol according to previous maintenance long acting beta-agonist use","volume":"24","author":"Langley","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD002876.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2710.2005.00686.x","article-title":"Does pulmonary rehabilitation give additional benefit over tiotropium therapy in primary care management of chronic obstructive pulmonary disease? Randomized controlled clinical trial in Hong Kong Chinese","volume":"30","author":"Lindsay","year":"2005","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002876.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","article-title":"Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD","volume":"128","author":"Maltais","year":"2005","journal-title":"Chest"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0045|cit45","unstructured":"O'Donnell D Hamilton A Kesten S Influence of the exercise-limiting symptom on the relationship between lung hyperinflation and endurance time in COPD patients treated with tiotropium American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 B23 Poster 502"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0046|cit46","first-page":"323s","article-title":"Reproducibility of measurements of inspiratory capacity dyspnea intensity and exercise endurance in multicentre trials in COPD","volume":"24","author":"O'Donnell","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0047|cit47","first-page":"214s","article-title":"Inspiratory capacity (IC) and dyspnea during recovery from symptom-limited exercise in COPD patients treated with tiotropium","volume":"24","author":"O'Donnell","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD002876.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1183\/09031936.06.00062705","article-title":"The effect of tiotropium on exacerbations and airflow in patients with COPD","volume":"27","author":"Dusser","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0049|cit49","first-page":"513s","article-title":"Tiotropium reduces health resource utilization associated with COPD exacerbations","volume":"24","author":"Dusser","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0050|cit50","first-page":"513s","article-title":"Tiotropium COPD exacerbations the MISTRAL study","volume":"24","author":"Dusser","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0051|cit51","unstructured":"Dusser D Viel K Bravo ML Iacono P Tiotropium reduces moderate-to-severe exacerbations in COPD patients irrespective of concomitant use of inhaled corticosteroids (ICS) Proceedings of the American Thoracic Society 2006 A603"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0052|cit52","first-page":"A603","article-title":"Tiotropium reduces COPD exacerbations requiring treatment with systemic corticosteroids, antibiotics, or hospitalizations","author":"Dusser","year":"2006","journal-title":"Proceedings of the American Thoracic Society"},{"issue":"1","key":"10.1002\/14651858.CD002876.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pupt.2007.04.003","article-title":"Tiotropium improves FEV(1) in patients with COPD irrespective of smoking status","volume":"21","author":"Moita","year":"2008","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD002876.pub2-BIB0054|cit54","first-page":"Abstract No: 19","article-title":"The effect of tiotropium bromide in a stable cohort of COPD patients in Portugal","volume":"26","author":"Moita","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0055|cit55","unstructured":"Powrie D Wilkinson T Donaldson G Viel K Jones P Scrine K The effect of tiotropium on diary based exacerbation frequency in COPD Proceedings of the American Thoracic Society 2006 A604"},{"issue":"3","key":"10.1002\/14651858.CD002876.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/09031936.00023907","article-title":"Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD","volume":"30","author":"Powrie","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0057|cit57","article-title":"Spiriva\u00ae Assessment of FEV1 (SAFE). The effect of inhaled tiotropium bromide (18 mcg once daily) on the change in FEV1 during long-term treatment in patients with COPD. A one-year parallel group, double-blind, randomised, placebo-controlled study","author":"205.259","journal-title":"http:\/\/trials.boehringer-ingelheim.com (31st January 2008)"},{"issue":"8","key":"10.1002\/14651858.CD002876.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1155\/2007\/192961","article-title":"A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease","volume":"14","author":"Chan","year":"2007","journal-title":"Canadian Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1465-9921-8-45","article-title":"Efficacy and safety of tiotropium in COPD patients in primary care - the SPiRiva Usual CarE (SPRUCE) study","volume":"8","author":"Freeman","year":"2007","journal-title":"Respiratory Research"},{"issue":"Suppl ii","key":"10.1002\/14651858.CD002876.pub2-BIB0060|cit60","first-page":"100","article-title":"Spruce: tiotropium in a UK primary care","volume":"59","author":"Freeman","year":"2004","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0061|cit61","unstructured":"Price D Sarno M Lee A Freeman D SPiRiva usual carE- SPRUCE - tiotropium in a UK primary care COPD population other regular inhaled treatment American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 A43 Poster: F26"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0062|cit62","unstructured":"Tonnel AB Bravo M-L Brun M Clinically significant improvements of health status of COPD patients after 9 months treatment with tiotropium bromide the TIPHON stud American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 B93 Poster: 302"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD002876.pub2-BIB0063|cit63","first-page":"Abstract No: 19","article-title":"Improvement in HRQoL of COPD patients after 9 months treatment with tiotropium bromide: use of a new scale for daily medical practice","volume":"26","author":"Tonnel","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"Suppl 51","key":"10.1002\/14651858.CD002876.pub2-BIB0064|cit64","first-page":"525s","article-title":"Frequency of acute flow and volume responses to bronchodilator administration in patients with COPD","volume":"30","author":"Celli","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD002876.pub2-BIB0065|cit65","first-page":"716s","article-title":"Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators","volume":"26","author":"Celli","year":"2005","journal-title":"European RespiratorY Journal"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD002876.pub2-BIB0066|cit66","first-page":"526s","article-title":"Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial","volume":"28","author":"Decramer","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD002876.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1081\/COPD-200026934","article-title":"Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial","volume":"1","author":"Decramer","year":"2004","journal-title":"Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD002876.pub2-BIB0068|cit68","first-page":"32s","article-title":"Effectiveness of a spirometric quality assurance program in a large-scale global COPD trial (UPLIFT)","volume":"24","author":"Decramer","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD002876.pub2-BIB0070|cit69","first-page":"470s","article-title":"EQ-5D discriminates between COPD patients of different severity","volume":"26","author":"Rutten-van Molken","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD002876.pub2-BIB0069|cit70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1378\/chest.130.4.1117","article-title":"Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?","volume":"130","author":"Rutten-van M\u00f6lken","year":"2006","journal-title":"Chest"},{"issue":"Suppl 49","key":"10.1002\/14651858.CD002876.pub2-BIB0071|cit71","first-page":"Abstract No. 42","article-title":"Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT)","volume":"26","author":"Tashkin","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0072|cit72","first-page":"B93 Poster: 311","article-title":"A comparison of the 24 hour bronchodilator effect of tiotropium QD [T10] salmeterol BID [SALM] or their combination in COPD","author":"Noord","year":"2005","journal-title":"American Thoracic Society 2005 International Conference; May 20-25; San Diego, California"},{"issue":"2","key":"10.1002\/14651858.CD002876.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.05.00140404","article-title":"Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD","volume":"26","author":"Noord","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0074|cit74","unstructured":"van Noord JA Smeets JJ Otte A Bindels H Mueller A Cornellissen PJG The effect of tiotropium, salmeterol and it's combination on dynamic hyperinflation in COPD American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 B93 Poster: 310"},{"issue":"4","key":"10.1002\/14651858.CD002876.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000089655","article-title":"The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease","volume":"73","author":"Verkindre","year":"2006","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0076|cit76","article-title":"A randomised, double-blind, double-dummy, placebo- and active-controlled, parallel group efficacy and safety comparison of 12-week treatment of two doses [5 mg (2 actuations of 2.5 mg) and 10 mg (2 actuations of 5 mg)] of tiotropium inhalation solution delivered by the Respimat Inhaler, placebo and ipratropium bromide inhalation aerosol (MDI) in patients with Chronic Obstructive Pulmonary Disease (COPD)","author":"Boehringer","journal-title":"http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0077|cit77","unstructured":"Boehringer Ingelheim A randomised, double-blind, double-dummy, placebo- and active-controlled, parallel group efficacy and safety comparison of 12-week treatment of two doses [5 mg (2 actuations of 2.5 mg) and 10 mg (2 actuations of 5 mg)] of tiotropium inhalation solution delivered by the Respimat Inhaler, placebo and ipratropium bromide inhalation aerosol (MDI) in patients with chronic obstructive pulmonary disease (COPD) http:\/\/trials.boehringer-ingelheim.com (accessed 31st January 2008)"},{"issue":"1","key":"10.1002\/14651858.CD002876.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2007.08.009","article-title":"A randomized study of tiotropium Respimat\u00ae Soft MistTM Inhaler versus ipratropium pMDI in COPD","volume":"102","author":"Voshaar","year":"2008","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.1994.03520190043033","article-title":"Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study","volume":"272","author":"Anthonisen","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/rccm.2110093","article-title":"Hospitalizations and Mortality in the Lung Health Study","volume":"166","author":"Anthonisen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1378\/chest.117.2_suppl.63S","article-title":"The pharmacological properties of tiotropium","volume":"117(2 Suppl)","author":"Barnes","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD002876.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009552","article-title":"Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease","author":"Cheyne","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD002876.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009157","article-title":"Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease","author":"Chong","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"64","key":"10.1002\/14651858.CD002876.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0024-3205(98)00588-8","article-title":"Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease","author":"Disse","year":"1999","journal-title":"Life Sci"},{"issue":"328","key":"10.1002\/14651858.CD002876.pub2-BIB0085|cit85","first-page":"1017","article-title":"Management of chronic obstructive pulmonary disease","author":"Ferguson","year":"1993","journal-title":"N Engl J Med"},{"issue":"45","key":"10.1002\/14651858.CD002876.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0026-895X(25)10204-6","article-title":"Characterization of 3H Ba 679 BR, a slowly dissociation muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping","author":"Haddad","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1002\/14651858.CD002876.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009285.pub2","article-title":"Tiotropium versus placebo for chronic obstructive pulmonary disease","author":"Karner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0088|cit88","first-page":"1","article-title":"Chronic obstructive pulmonary disease surveillance -- United States, 1971-2000","volume":"51(SS-6)","author":"Mannino","year":"2002","journal-title":"MMWR"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1183\/09031936.03.00083703","article-title":"One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease","volume":"23","author":"Oostenbrink","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.290.17.2301","article-title":"Contemporary management of chronic obstructive pulmonary disease: scientific review","volume":"290","author":"Sin","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002876.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thorax.58.11.937","article-title":"Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis","volume":"58","author":"Sutherland","year":"2003","journal-title":"Thorax"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002876.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:02:29Z","timestamp":1747296149000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002876.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002876.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,20]]}}}